GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SCYX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for SCYNEXIS stock after gaining 2.49%
(Updated on Apr 19, 2024)

Sell candidate since Apr 10, 2024 Loss -8.86% PDF

The SCYNEXIS stock price gained 2.49% on the last trading day (Friday, 19th Apr 2024), rising from $1.41 to $1.44. During the last trading day the stock fluctuated 5.75% from a day low at $1.39 to a day high of $1.47. The price has fallen in 5 of the last 10 days and is down by -15.79% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 51 thousand more shares were traded than the day before. In total, 131 thousand shares were bought and sold for approximately $188.46 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.03% during the next 3 months and, with a 90% probability hold a price between $0.91 and $1.27 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SCYX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 2.49%. Further rise is indicated until a new top pivot has been found. SCYNEXIS has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The SCYNEXIS stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.46 and $1.53. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for SCYNEXIS stock

SCYNEXIS finds support from accumulated volume at $1.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0799 between high and low, or 5.75%. For the last week, the stock has had daily average volatility of 6.26%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SCYX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect SCYNEXIS to open at $1.43, and during the day (based on 14 day Average True Range), to move between $1.33 and $1.55, which gives a possible trading interval of +/-$0.109 (+/-7.60%) up or down from last closing price. If SCYNEXIS takes out the full calculated possible swing range there will be an estimated 15.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.45 (0.69%) than the support at $1.41 (2.08%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is SCYNEXIS stock A Buy?

SCYNEXIS holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.316 Sell Candidate Unchanged

Predicted Opening Price for SCYNEXIS of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$1.43 ( 0.465%) $1.44

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SCYX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.51 5.08 %
R2 1.48 2.96 %
R1 1.46 1.65 %
Current price: 1.44
Support S1 1.40 -2.58 %
S2 1.38 -3.89 %
S3 1.35 -6.01 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.63 13.19 %
R2 1.60 11.11 %
R1 1.45 0.694 %
Current price 1.44
Support S1 1.41 -2.08%
S2 1.40 -2.78%
S3 1.39 -3.47%

FAQ

What is the symbol for SCYNEXIS Stock and on which exchange is it traded?
The symbol for SCYNEXIS is SCYX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell SCYNEXIS Stock?
SCYNEXIS holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy SCYNEXIS Stock?
SCYNEXIS Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy SCYNEXIS Stock.

What's the current price of SCYNEXIS Stock?
As of the end of day on the 2024-04-19, the price of an SCYNEXIS (SCYX) share was $1.44.

What is the 52-week high and low for SCYNEXIS Stock?
The 52-week high for SCYNEXIS Stock is $3.87 and the 52-week low is $1.35.

What is the market capitalization of SCYNEXIS Stock?
As of the 2024-04-19, the market capitalization of SCYNEXIS is 53.61M.

When is the next earnings date for SCYNEXIS?
The upcoming earnings date for SCYNEXIS is May 09, 2024.
Click to get the best stock tips daily for free!

About SCYNEXIS

SCYNEXIS SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refrac... SCYX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT